Abstract:Two luminescent cyclometallated Ir III complexes of the type [Ir(C^N) 2 (N^N)] x (X = 0 ( 1 ), and X = +1 ( 2 )) were prepared using methyl 2-phenylquinoline-4-carboxylate as C^N ligands and either a deprotonated or protonated 3-(2-pyridyl)pyrazole as the N^N chelate. The synthesis followed a well-established and straightforward procedure. Photophysical analysis unveiled their remarkable properties, featuring phosphorescent red and orange emissions attributed to 3 MLCT and 3 LLCT transitions, with high emissive quantum yields in degassed DMSO solutions. Importantly, these complexes exhibited dual functionality as potent chemotherapeutic agents and photosensitisers, with their effectiveness tailored to specific cancer cell lines. Phototherapeutic treatment was particularly effective against lung cancer A549 cells, while a chemotherapeutic approach yielded superior results against breast cancer 4T1-luc2 cells. Both complexes primarily targeted lysosomes, leading to cell death through apoptotic pathways, with IC50 values in the nanomolar range. Importantly, they demonstrated no cytotoxicity against lymphocytes, mimicking the behaviour observed in healthy cells. Encouragingly, 1 and 2 exhibited minimal in vivo toxicity. The most striking finding was the exceptional chemotherapeutic efficacy of complexes 1 and 2 against 4T1-luc2 cells in BALB/c mice. These complexes surpassed the performance of the clinically employed 5-fluorouracil, especially at early tumor stages, significantly retarding 4T1-luc2 proliferation. Further investigations at vascularised and organised tumor stages revealed that complex 1 could reduce tumor size by half compared to untreated mice, which was also confirmed through tumoral weight analysis. While these findings are preliminary, the outstanding performance of these complexes at early tumor stages against breast cancer 4T1-luc2 in vivo, their selective therapeutic feasibility (chemotherapy vs. PDT) tailored to specific cancerous cell lines, and their straightforward synthetic design make them highly attractive candidates for cancer treatment.

Development of Cyclometalated Iridium(III) Complexes of 2‐Phenylbenzimidazole and Bipyridine Ligands for Selective Elimination of Gram‐Positive Bacteria

An AIE-Active Cyclometalated Iridium(III) Photosensitizer for Selective Discrimination, Imaging, and Synergistic Elimination of Gram-Positive Bacteria

Application of Mono and Trinuclear Cyclometalated Iridium (III) Complexes in Differential Bacterial Imaging and Antimicrobial Photodynamic therapy

Rational Design and Synthesis of AIE Active Cationic Ir(III) Complexes Featuring Iminopyridine Ligand with Dibenzosuberane Core

Tricyclic 2-Aminopyridinium Derivatives with Aggregation-Induced Emission for Concomitant Bacterial Discrimination and Inhibition

Amine-substituted heterocyclic thioamide Cu(I) and Ag(I) complexes as effective anticancer and antibacterial agents targeting the periplasm of E. coli bacteria

Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis

Cationic Tricyclic AIEgens for Concomitant Bacterial Discrimination and Inhibition

Synthesis, Characterization and Biological Evaluation of Two Cyclometalated Iridium(iii) Complexes Containing a Glutathione S-transferase Inhibitor.

2‐thiophenyl‐isoquinoline Ir(III) complex as red absorbing photosensitizer: a promising tool in antipseudomonal photodynamic therapy

Cytotoxic and Apoptosis-Inducing Activities of Iridium Complexes Bearing 2-Phenylimidazo[4,5-f][1,10]-Phenanthroline Derivatives in Human Cancer Cells

Four cyclometalated Ir(iii) complexes and insights into their luminescence, cytotoxicity and DNA/BSA binding performance

A Cationic Iridium(Iii) Complex Showing Aggregation- Induced Phosphorescent Emission (Aipe) In The Solid State: Synthesis, Characterization And Properties

Stable Luminescent Iridium(iii) Complexes with Bis(n-Heterocyclic Carbene) Ligands: Photo-Stability, Excited State Properties, Visible-Light-driven Radical Cyclization and CO2 Reduction, and Cellular Imaging

Mitochondria-targeted Cyclometalated Iridium (III) Complexes: Dual Induction of A549 Cells Apoptosis and Autophagy.

Aggregation-Induced Emission-Based Ionic Liquids for Bacterial Killing, Imaging, Cell Labelling and Bacterial Detection in Blood Cells

Iridium(III) coordination compounds based on organophosphorus ancillary ligands showing cytotoxicity against breast cancer cells and Fe(III) luminescent sensing

Synthetic Ease and Exceptional In Vivo Performance of Pyrazole-based Cyclometallated Iridium Complexes

Synthesis and characterisation of phenanthroline-oxazine ligands and their Ag(I), Mn(II) and Cu(II) complexes and their evaluation as antibacterial agents

Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.